Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-16 · accession 0001209191-21-070692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-20 | 2021-12-16 | NKTR | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +126.0K | 601.5K | +27% | $0 |
| D | 2021-12-20 | 2021-12-16 | NKTR | ROBIN HOWARD W | Pres, CEO, Dir | A - Grant | $0.00 | +223.8K | 223.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | A | A | 126,050 | $0.00 | 601,500 | D | — | — | (F1) This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service. |
| 2 | Derivative | Stock Option | 2021-12-16 | A | A | 223,750 | $0.00 | 223,750 | D | $13.22 · — to 2029-12-15 | 223,750 Common Stock | (F2) This stock option vests over four years from the date of grant in equal monthly installments based on continued service. |